- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1374
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1374 companies
HLS Therapeutics
Market Cap: CA$170.2m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$5.40
7D
-4.4%
1Y
47.5%
LabGenomics
Market Cap: ₩171.5b
Engages in the research and development of biotechnology products in South Korea.
A084650
₩2,310.00
7D
-7.4%
1Y
-19.4%
Lincoln Pharmaceuticals
Market Cap: ₹10.8b
Engages in manufacturing and trading of pharmaceutical products in India.
531633
₹537.75
7D
-2.9%
1Y
-20.7%
HansBiomed
Market Cap: ₩170.9b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩13,160.00
7D
-17.6%
1Y
32.1%
Senhwa Biosciences
Market Cap: NT$3.7b
A drug development company, engages in the development of new drugs and targeted agents.
6492
NT$41.30
7D
3.5%
1Y
-24.5%
Jushi Holdings
Market Cap: US$120.3m
A vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States.
JUSH.F
US$0.61
7D
-3.1%
1Y
15.4%
Macrogen
Market Cap: ₩169.1b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩15,600.00
7D
-0.2%
1Y
-12.4%
Maxigen Biotech
Market Cap: NT$3.6b
Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$44.70
7D
-0.9%
1Y
5.5%
Ilsung Is
Market Cap: ₩164.8b
Operates as a pharmaceutical company in South Korea.
A003120
₩23,650.00
7D
-2.5%
1Y
41.8%
Oncopeptides
Market Cap: SEK 1.1b
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 4.82
7D
1.7%
1Y
121.6%
Inhibikase Therapeutics
Market Cap: US$115.5m
Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.
IKT
US$1.55
7D
-5.5%
1Y
32.5%
Uni-Bio Science Group
Market Cap: HK$889.7m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.15
7D
-2.0%
1Y
93.5%
Whan In PharmLtd
Market Cap: ₩161.5b
Manufactures and sells various pharmaceuticals products in South Korea.
A016580
₩10,580.00
7D
-5.7%
1Y
-21.4%
Prestige BioPharma
Market Cap: ₩161.2b
A biopharmaceutical company, engages in the research and development and marketing of biosimilars, first-in-class antibody drugs, and vaccines.
A950210
₩13,410.00
7D
-8.7%
1Y
-4.1%
Instil Bio
Market Cap: US$112.4m
A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.
TIL
US$16.93
7D
-15.1%
1Y
-74.2%
Sera Prognostics
Market Cap: US$112.3m
A women’s health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States.
SERA
US$3.09
7D
-6.4%
1Y
-59.8%
Kyung Dong Pharmaceutical
Market Cap: ₩158.1b
Manufactures and sells pharmaceuticals in South Korea.
A011040
₩5,870.00
7D
-0.2%
1Y
-6.8%
Darwin
Market Cap: €96.0m
Operates as a biotechnology company.
7V0
€8.00
7D
0%
1Y
26.0%
Fortress Biotech
Market Cap: US$111.6m
A biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products.
FBIO
US$3.91
7D
6.5%
1Y
162.4%
Syngen BiotechLtd
Market Cap: NT$3.3b
Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.
8279
NT$123.50
7D
-1.2%
1Y
-6.4%
Pacific Edge
Market Cap: NZ$190.1m
A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.
PEB
NZ$0.19
7D
4.5%
1Y
24.0%
Spero Therapeutics
Market Cap: US$109.2m
A clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.
SPRO
US$1.89
7D
-5.5%
1Y
44.3%
Darya-Varia Laboratoria
Market Cap: Rp1.8t
Manufactures and trades pharmaceutical products and cosmetics in Indonesia.
DVLA
Rp1,630.00
7D
0.9%
1Y
-2.7%
SYN-TECH Chem. & Pharm
Market Cap: NT$3.3b
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.
1777
NT$74.40
7D
-0.4%
1Y
-24.5%
BIO-FD&CLtd
Market Cap: ₩151.8b
Develops active ingredients for anti-aging cosmetics in South Korea.
A251120
₩17,460.00
7D
-3.3%
1Y
20.5%
Zentalis Pharmaceuticals
Market Cap: US$107.5m
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.
ZNTL
US$1.55
7D
2.0%
1Y
-58.7%
Eurofins-Cerep
Market Cap: €91.8m
Provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.
ALECR
€18,200.00
7D
0%
1Y
-15.0%
Apontis Pharma
Market Cap: €91.2m
Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
APPH
€10.95
7D
0%
1Y
71.1%
BIOTON
Market Cap: zł386.4m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł4.50
7D
0%
1Y
32.5%
Atossa Therapeutics
Market Cap: US$105.5m
Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.
ATOS
US$0.86
7D
1.2%
1Y
-43.1%
Oncodesign Société Anonyme
Market Cap: €99.4m
Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.
ALONC
€14.42
7D
0%
1Y
57.3%
Ind-Swift Laboratories
Market Cap: ₹9.3b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.
INDSWFTLAB
₹99.93
7D
-4.0%
1Y
-23.9%
Traphaco
Market Cap: ₫2.8t
Produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam.
TRA
₫66,800.00
7D
-0.3%
1Y
-13.5%
Entasis Therapeutics Holdings
Market Cap: US$104.8m
Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States.
ETTX
US$2.19
7D
0%
1Y
-14.8%
Fermenta Biotech
Market Cap: ₹9.3b
Manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally.
506414
₹314.55
7D
-6.6%
1Y
4.4%
MedPacto
Market Cap: ₩147.4b
A drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea.
A235980
₩4,300.00
7D
-6.3%
1Y
-31.0%